UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

The New England journal of medicine, 2012-12, Vol.367 (25), p.2385-2395

2012

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

Arthritis care & research (2010), 2010-01, Vol.62 (1), p.63-72

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.530-541

2021

Link zum Volltext

Verfügbarkeit prüfen

Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease

Glia, 2008-11, Vol.56 (14), p.1566-1577

2008

Link zum Volltext

Verfügbarkeit prüfen

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

The New England journal of medicine, 2012-12, Vol.367 (25), p.2396-2406

2012

Link zum Volltext

Verfügbarkeit prüfen

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2014-10, Vol.66 (10), p.2871-2880

2014

Link zum Volltext

Verfügbarkeit prüfen

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

The Lancet (British edition), 2016-02, Vol.387 (10019), p.671-678

2016

Link zum Volltext

Verfügbarkeit prüfen

The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination

Immunity (Cambridge, Mass.), 2022-10, Vol.55 (10), p.1924-1939.e5

2022

Link zum Volltext

Verfügbarkeit prüfen

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Arthritis & rheumatology (Hoboken, N.J.), 2016-03, Vol.68 (3), p.566-576

2016

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2010-04, Vol.303 (13), p.1266

2010

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

Arthritis & rheumatology (Hoboken, N.J.), 2015-10, Vol.67 (10), p.2759-2770

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Annals of the rheumatic diseases, 2010-04, Vol.69 (4), p.718-722

2010

Link zum Volltext

Verfügbarkeit prüfen

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.790-797

2010

Link zum Volltext

Verfügbarkeit prüfen

Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study

Annals of the rheumatic diseases, 2012-12, Vol.71 (12), p.1991-1997

2012

Link zum Volltext

Verfügbarkeit prüfen

MP50-12 BODY MASS INDEX, OBESITY AND ACUTE KIDNEY INJURY AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS FROM A HIGH-VOLUME ROBOTIC CENTER

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study

Arthritis & rheumatology (Hoboken, N.J.), 2018-07, Vol.70 (7), p.1144-1154

2018

Link zum Volltext

Verfügbarkeit prüfen

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

The Lancet (British edition), 2008-08, Vol.372 (9636), p.383-391

2008

Link zum Volltext

Verfügbarkeit prüfen

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

The Journal of pediatrics, 2017-10, Vol.189, p.72-78.e3

2017

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4568-4580

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study

Annals of the rheumatic diseases, 2013-09, Vol.72 (9), p.1503-1509

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(64)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(42)
Rheumatology
(36)
Child
(33)
Female
(28)
Male
(28)
Adolescent
(26)
Treatment Outcome
(22)
Arthritis, Juvenile - Drug Therapy
(19)
Biological And Medical Sciences
(19)
Child, Preschool
(19)
Medical Sciences
(19)
Diseases Of The Osteoarticular System
(18)
Inflammatory Joint Diseases
(11)
Antirheumatic Agents - Therapeutic Use
(9)
Immunology
(9)
Patients
(9)
Arthritis
(8)
Double-Blind Method
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study

The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination

The long term vaccine‐induced anti‐SARS‐CoV‐2 immune response is impaired in quantity and quality under TNFα blockade

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial

Long‐Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study

MP50-12 BODY MASS INDEX, OBESITY AND ACUTE KIDNEY INJURY AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS FROM A HIGH-VOLUME ROBOTIC CENTER

Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis

Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study

Aktive Filter

Suchergebnisse filtern